Mucormycosis is an aggressive, opportunistic infection caused by fungi belonging to the class of Phycomycetes. Rhino-occulo-cerebral mucormycosis is the commonest anatomical presentation of mucormycosis and is a potentially fatal disease. We report here a case of a 65-year-old diabetic female who presented with a locally invasive type of mucormycosis and was treated successfully by surgical debridement along with medical treatment (Amphoterecin-B and insulin).
Get full access to this article
View all access options for this article.
References
1.
SpellbergB, EdwardsJ, IbrahimA. Novel perspectives on mucormycosis: pathophysiology, presentation and management. Clin Microbiol Rev2005;18:556–9
2.
SugarAM. Mucormycosis. In: KasperDL, BraunwaldE, FauciAS, HauserSL, LongoDL, JamesonL, eds. Harrison Principles of Internal Medicine, 17th edn. New York: McGraw-Hill, 2008:1261–3
3.
TalwalkarPG. Rhino-occulo-cerebral mucormycosis in patients with type 2 diabetes mellitus. J Assoc Phys India2009;57:408–9
4.
DiwakarM, ThakurA, BahadurS. Improving outcomes in rhinocerebral-mucormycosis – early diagnostic pointers and prognostic factors. J Laryngol Otol2003;117:861–5
5.
AlobidI, BernalM, CavloC, Treatment of rhino-cerebral-mucormycosis by a combination of endoscopic debridement and amphoterecin B. Am J Rhinol2001;15:327–31
